Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
The Latest on: Drug-delivery nanoparticles
via Google News
The Latest on: Drug-delivery nanoparticles
- Adelaide researchers proud to see nanotech drug delivery method reach clinical trialon October 6, 2020 at 8:03 pm
Using the magic of nanotechnology, Adelaide scientists have devised a new method of drug delivery that means more medicine enters the bloodstream.
- 'Like a fishing net,' nanonet collapses to trap drug moleculeson October 6, 2020 at 12:49 am
The novel method presents new possibilities for diverse applications, including water purification, diagnostics and rapidly generating vaccine formulations, which typically require many different ...
- Nanoparticle-Based Vaccineson October 5, 2020 at 5:10 am
Nanoparticle-based vaccines exhibit a wide range of advantageous physicochemical properties that can aid in the targeted delivery of novel vaccines.
- Zebrafish Embryo Model Helps Understand the Workings of Nanoparticles in Bloodon October 1, 2020 at 7:39 am
A wide range of nanoparticles are engineered for targeted drug delivery, but regrettably, just a few of the injected nanoparticles reach the site of target, such as solid tumors. The reason for this ...
- Zebrafish embryos help prove what happens to nanoparticles in the bloodon September 30, 2020 at 9:53 am
A variety of nanoparticles are designed for targeted drug delivery, but unfortunately only a very small proportion of the injected nanoparticles reach the target site such as solid tumors.
- Gold Nanoparticles Market Report 2020 : Rising Impressive Business Opportunities Analysis with Top Countries Data Forecast By 2026on September 30, 2020 at 12:38 am
Gold Nanoparticles Market" is valued at 69 million USD in 2020 is expected to reach 158.5 million USD by the end of ...
- 'Rubbery' RNA nanoparticles squeeze through tumors for safer delivery of cancer drugs: studyon September 28, 2020 at 8:04 am
That could allow the nanoparticles to breach the poorly formed walls of tumor blood vessels to enter tumor masses and make them a safer drug delivery option for anti-cancer drugs, too, the team ...
- Carmine Therapeuticson September 28, 2020 at 12:00 am
Yet, exosomes pose their own problems, creating an opportunity for Carmine Therapeutics to use its novel approach to establish itself as a next-generation, non-viral gene therapy company. What makes ...
- Novel Drug Delivery Systems (NDDS) Research Report 2020 - Global Market Trajectory & Analytics 2012-2027 - ResearchAndMarkets.comon September 25, 2020 at 4:48 am
Nanoparticles, one of the segments analyzed ... While China is Forecast to Grow at 19.3% CAGR The Novel Drug Delivery Systems (NDDS) market in the U. S. is estimated at US$2.3 Billion in the ...
- Novel Drug Delivery Systems (NDDS) Research Report 2020 - Global Market Trajectory & Analytics 2012-2027 - ResearchAndMarkets.comon September 25, 2020 at 2:51 am
Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$7.7 ...
via Bing News